Last update 01 Jun 2025

CJ-15314

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CJ 15314, IN-115314, IN-A002
Target
JAK1
Action
inhibitors
Mechanism
JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors)
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication
Dermatitis, AtopicAutoimmune Diseases
Inactive Indication
Mild Atopic DermatitisModerate Atopic Dermatitis
Originator Organization
HK inno.N Corp.HK inno.N Corp.
Active Organization
HK inno.N Corp.HK inno.N Corp.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with CJ-15314
NCT05729074
/ Unknown statusPhase 1
A Randomized, Placebo/Active Controlled, Single/Multiple Dosing, Dose Escalation Clinical Phase 1a/b Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
NCT05019755
/ Unknown statusPhase 1
A Randomized, Open-label, Single-dose, 2-way Crossover Clinical Trial to Investigate the Effect of Food on the Pharmacokinetics of IN-A002 Capsule in Healthy Male Subjects
NCT04297865
/ Unknown statusPhase 1
A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects
100 Clinical Results associated with CJ-15314
Login to view more data
100 Translational Medicine associated with CJ-15314
Login to view more data
100 Patents (Medical) associated with CJ-15314
Login to view more data
100 Deals associated with CJ-15314
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dermatitis, AtopicPhase 2
South Korea
HK inno.N Corp.HK inno.N Corp.
17 Mar 2025
Autoimmune DiseasesPhase 1-
HK inno.N Corp.HK inno.N Corp.
20 Jun 2023
Mild Atopic DermatitisPhase 1-
HK inno.N Corp.HK inno.N Corp.
13 Feb 2023
Moderate Atopic DermatitisPhase 1-
HK inno.N Corp.HK inno.N Corp.
13 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free